<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    OpGen, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About OpGen, Inc.

    OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      8071
    • NIN CODE
      ####
    • LEADERSHIP
      Evan Jones
    • FOUNDED
      2002
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Aytu BioScience, Inc.

    Aytu BioScience, Inc.

    Aytu is committed to better health for men and women here at home and worldwide. W...

    Aytu is committed to better health for men and ...

    Filing Type:    PU
    Sonova Holding AG

    Sonova Holding AG

    Sonova, headquartered in Stäfa, Switzerland, is a leading provider of innovative h...

    Sonova, headquartered in Stäfa, Switzerland, is...

    Filing Type:    PU
    WinSanTor, Inc.

    WinSanTor, Inc.

    WinSanTor’s mission is simple-develop a drug that works. We recognize that there...

    WinSanTor’s mission is simple-develop a drug ...

    Amount Raised:    $572,649.00
    Fundraising Status:    EC
    Filing Type:    CF
    Axcella Health Inc.

    Axcella Health Inc.

    Axcella is designing and developing AXA Candidates, compositions of endogenous met...

    Axcella is designing and developing AXA Candida...

    Filing Type:    PU
    Establishment Labs Holdings Inc.

    Establishment Labs Holdings Inc.

    Establishment Labs is a global medical technology company focused on improving pat...

    Establishment Labs is a global medical technolo...

    Filing Type:    PU
    ADiTx Therapeutics, Inc

    ADiTx Therapeutics, Inc

    The discovery of immunosuppressive (anti-rejection) drugs has made possible life-s...

    The discovery of immunosuppressive (anti-reject...

    Filing Type:    RA
    Genobank.io Inc

    Genobank.io Inc

    Genobank is the first privacy-preserving personal DNA Kit that guarantees consumer...

    Genobank is the first privacy-preserving person...

    Amount Raised:    $156,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Illumina, Inc.

    Illumina, Inc.

    A global leader in DNA sequencing and array-based technologies, Illumina is fuelin...

    A global leader in DNA sequencing and array-bas...

    Filing Type:    PU
    H & G Science, Inc.

    H & G Science, Inc.

    H&G Science aims to facilitate the safe and effective treatment of diseases. Our g...

    H&G Science aims to facilitate the safe and eff...

    Amount Raised:    $24,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Traqiq, Inc

    Traqiq, Inc

    TraqIQ is a publicly held, fully reporting company with multiple operating subsidi...

    TraqIQ is a publicly held, fully reporting comp...

    Filing Type:    RA
    SynTouch, Inc.

    SynTouch, Inc.

    The mathematical models based on proven haptics science produced by the SynTouch T...

    The mathematical models based on proven haptics...

    Amount Raised:    $1,734,253.39
    Fundraising Status:    SD
    Filing Type:    CF
    Huron Consulting Group Inc.

    Huron Consulting Group Inc.

    Huron is committed to creating value for our clients, people and shareholders. As ...

    Huron is committed to creating value for our cl...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.